Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 30,829 | 25,000 | 0 | 0 | 0 |
| Gross Profit | 30,829 | 25,000 | N/A | N/A | N/A |
| Operating Expenses | 268,829 | 186,836 | 77,724 | 25,640 | 16,729 |
| Operating Income | -238,000 | -161,836 | -77,724 | -25,640 | -16,729 |
| Other Income | 1,449 | 4,544 | 5,593 | 855 | 136 |
| Pre-tax Income | -236,551 | -157,292 | -72,131 | -24,785 | -16,593 |
| Net Income Continuous | -236,551 | -157,292 | -72,131 | -24,785 | -16,593 |
| Net Income | $-236,551 | $-157,292 | $-72,131 | $-24,785 | $-16,593 |
| EPS Basic Total Ops | -4.80 | -3.85 | -2.99 | -7.31 | -4.97 |
| EPS Basic Continuous Ops | -4.80 | -3.85 | -2.99 | -7.31 | -4.97 |
| EPS Diluted Total Ops | -4.80 | -3.85 | -2.99 | -7.31 | -4.97 |
| EPS Diluted Continuous Ops | -4.80 | -3.85 | -2.99 | -7.31 | -4.97 |
| EPS Diluted Before Non-Recurring Items | -4.80 | -3.85 | -2.99 | N/A | N/A |
| EBITDA(a) | $-228,700 | $-158,182 | $-77,502 | $-25,502 | $-16,666 |